Literature DB >> 18299611

Predicting fluorouracil toxicity: can we finally do it?

Hany H Ezzeldin, Robert B Diasio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299611     DOI: 10.1200/JCO.2007.15.5481

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

Review 1.  Colorectal cancer molecular biology moves into clinical practice.

Authors:  Colin C Pritchard; William M Grady
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

Review 2.  Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact.

Authors:  Federico M Goodsaid; Shashi Amur; Jiri Aubrecht; Michael E Burczynski; Kevin Carl; Jennifer Catalano; Rosane Charlab; Sandra Close; Catherine Cornu-Artis; Laurent Essioux; Albert J Fornace; Lois Hinman; Huixiao Hong; Ian Hunt; David Jacobson-Kram; Ansar Jawaid; David Laurie; Lawrence Lesko; Heng-Hong Li; Klaus Lindpaintner; James Mayne; Peter Morrow; Marisa Papaluca-Amati; Timothy W Robison; John Roth; Ina Schuppe-Koistinen; Leming Shi; Olivia Spleiss; Weida Tong; Sharada L Truter; Jacky Vonderscher; Agnes Westelinck; Li Zhang; Issam Zineh
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

3.  Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction.

Authors:  Guido Bocci; Antonello Di Paolo; Cecilia Barbara; Gianluca Masi; Lorenzo Fornaro; Fotios Loupakis; Giacomo Allegrini; Alfredo Falcone; Mario Del Tacca; Romano Danesi
Journal:  Br J Clin Pharmacol       Date:  2008-11-05       Impact factor: 4.335

4.  Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.

Authors:  Patrick Thurner; Christian Nanoff
Journal:  Breast Care (Basel)       Date:  2008-11-25       Impact factor: 2.860

Review 5.  Molecular alterations and biomarkers in colorectal cancer.

Authors:  William M Grady; Colin C Pritchard
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

6.  Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.

Authors:  J M Bowen; I White; L Smith; A Tsykin; K Kristaly; S K Thompson; C S Karapetis; H Tan; P A Game; T Irvine; D J Hussey; D I Watson; D M K Keefe
Journal:  Support Care Cancer       Date:  2015-03-27       Impact factor: 3.603

7.  Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.

Authors:  Joana Savva-Bordalo; João Ramalho-Carvalho; Manuela Pinheiro; Vera L Costa; Angelo Rodrigues; Paula C Dias; Isabel Veiga; Manuela Machado; Manuel R Teixeira; Rui Henrique; Carmen Jerónimo
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

Review 8.  Genetic prognostic and predictive markers in colorectal cancer.

Authors:  Axel Walther; Elaine Johnstone; Charles Swanton; Rachel Midgley; Ian Tomlinson; David Kerr
Journal:  Nat Rev Cancer       Date:  2009-06-18       Impact factor: 60.716

9.  Gastric cancer: Classification, histology and application of molecular pathology.

Authors:  Bing Hu; Nassim El Hajj; Scott Sittler; Nancy Lammert; Robert Barnes; Aurelia Meloni-Ehrig
Journal:  J Gastrointest Oncol       Date:  2012-09

10.  Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes.

Authors:  Muhammad Wasif M Saif; Ruchi Hamal; Nauman Siddiqui; Antonia Maloney; Melissa Smith
Journal:  Therap Adv Gastroenterol       Date:  2021-07-03       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.